# A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT)

> **NCT00307814** · PHASE2 · COMPLETED · sponsor: **Ortho Biotech Products, L.P.** · enrollment: 519 (actual)

## Conditions studied

- Anemia
- Chronic Renal Insufficiency

## Interventions

- **DRUG:** Epoetin Alfa

## Key facts

- **NCT ID:** NCT00307814
- **Lead sponsor:** Ortho Biotech Products, L.P.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2004-01
- **Target enrollment:** 519 (ACTUAL)
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00307814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00307814, "A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT)". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00307814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*